Cargando…

Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using (18)F-FDG positron emission tomography: a retrospective cohort study

BACKGROUND: The results of treatment for malignant bone and soft-tissue tumors arising from the deep trunk and pelvis are still not acceptable due to the relatively high recurrence and low overall survival rates. Recently, carbon ion radiotherapy (CIRT) was applied for several malignancies, includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagawa, Takashi, Saito, Kenichi, Kiyohara, Hiroki, Ohno, Tatsuya, Nakano, Takashi, Takagishi, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687301/
https://www.ncbi.nlm.nih.gov/pubmed/26691334
http://dx.doi.org/10.1186/s13014-015-0571-9
_version_ 1782406607465873408
author Yanagawa, Takashi
Saito, Kenichi
Kiyohara, Hiroki
Ohno, Tatsuya
Nakano, Takashi
Takagishi, Kenji
author_facet Yanagawa, Takashi
Saito, Kenichi
Kiyohara, Hiroki
Ohno, Tatsuya
Nakano, Takashi
Takagishi, Kenji
author_sort Yanagawa, Takashi
collection PubMed
description BACKGROUND: The results of treatment for malignant bone and soft-tissue tumors arising from the deep trunk and pelvis are still not acceptable due to the relatively high recurrence and low overall survival rates. Recently, carbon ion radiotherapy (CIRT) was applied for several malignancies, including bone and soft-tissue sarcomas, and provided favorable results. However, it has been unclear what modalities should be used for evaluating the response and for the follow-up of these patients. Here, we analyzed the methods used to predict local recurrence and to find local failures or metastases. METHODS: We analyzed 37 patients with bone and soft-tissue tumors who received CIRT at our institute. The patients were examined with FDG positron emission tomography (PET) and enhanced MRI before and three months after CIRT. The pre-treatment maximum standardized uptake value (SUVmax), and that three months after treatment, the difference between the pre- and post-CIRT SUVmax, the ratio of the post- to pre-SUVmax in FDG-PET and the size of the tumors were evaluated as predictors for local recurrence. FDG-PET and enhanced MRI were used to detect local recurrence. RESULTS: Local recurrence appeared in 10 cases after CIRT. Nine of the 10 lesions (90.0 %) were detected with FDG-PET, while enhanced MRI detected just 50.0 % of the recurrences. One case of local recurrence, in which the lesion was negative on FDG-PET, was detected using enhanced MRI. A receiver operating characteristic curve analysis showed that neither the SUVmax on FDG-PET nor the tumor size before or three months after CIRT could be used to predict local recurrence. CONCLUSIONS: The combination of FDG-PET and enhanced MRI is recommended to detect local recurrence for patients with sarcomas who have received CIRT; however, no parameters obtained during the examinations performed before and three months after CIRT accurately predicted the development of local recurrence.
format Online
Article
Text
id pubmed-4687301
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46873012015-12-23 Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using (18)F-FDG positron emission tomography: a retrospective cohort study Yanagawa, Takashi Saito, Kenichi Kiyohara, Hiroki Ohno, Tatsuya Nakano, Takashi Takagishi, Kenji Radiat Oncol Research BACKGROUND: The results of treatment for malignant bone and soft-tissue tumors arising from the deep trunk and pelvis are still not acceptable due to the relatively high recurrence and low overall survival rates. Recently, carbon ion radiotherapy (CIRT) was applied for several malignancies, including bone and soft-tissue sarcomas, and provided favorable results. However, it has been unclear what modalities should be used for evaluating the response and for the follow-up of these patients. Here, we analyzed the methods used to predict local recurrence and to find local failures or metastases. METHODS: We analyzed 37 patients with bone and soft-tissue tumors who received CIRT at our institute. The patients were examined with FDG positron emission tomography (PET) and enhanced MRI before and three months after CIRT. The pre-treatment maximum standardized uptake value (SUVmax), and that three months after treatment, the difference between the pre- and post-CIRT SUVmax, the ratio of the post- to pre-SUVmax in FDG-PET and the size of the tumors were evaluated as predictors for local recurrence. FDG-PET and enhanced MRI were used to detect local recurrence. RESULTS: Local recurrence appeared in 10 cases after CIRT. Nine of the 10 lesions (90.0 %) were detected with FDG-PET, while enhanced MRI detected just 50.0 % of the recurrences. One case of local recurrence, in which the lesion was negative on FDG-PET, was detected using enhanced MRI. A receiver operating characteristic curve analysis showed that neither the SUVmax on FDG-PET nor the tumor size before or three months after CIRT could be used to predict local recurrence. CONCLUSIONS: The combination of FDG-PET and enhanced MRI is recommended to detect local recurrence for patients with sarcomas who have received CIRT; however, no parameters obtained during the examinations performed before and three months after CIRT accurately predicted the development of local recurrence. BioMed Central 2015-12-21 /pmc/articles/PMC4687301/ /pubmed/26691334 http://dx.doi.org/10.1186/s13014-015-0571-9 Text en © Yanagawa et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yanagawa, Takashi
Saito, Kenichi
Kiyohara, Hiroki
Ohno, Tatsuya
Nakano, Takashi
Takagishi, Kenji
Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using (18)F-FDG positron emission tomography: a retrospective cohort study
title Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using (18)F-FDG positron emission tomography: a retrospective cohort study
title_full Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using (18)F-FDG positron emission tomography: a retrospective cohort study
title_fullStr Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using (18)F-FDG positron emission tomography: a retrospective cohort study
title_full_unstemmed Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using (18)F-FDG positron emission tomography: a retrospective cohort study
title_short Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using (18)F-FDG positron emission tomography: a retrospective cohort study
title_sort monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using (18)f-fdg positron emission tomography: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687301/
https://www.ncbi.nlm.nih.gov/pubmed/26691334
http://dx.doi.org/10.1186/s13014-015-0571-9
work_keys_str_mv AT yanagawatakashi monitoringboneandsofttissuetumorsaftercarbonionradiotherapyusing18ffdgpositronemissiontomographyaretrospectivecohortstudy
AT saitokenichi monitoringboneandsofttissuetumorsaftercarbonionradiotherapyusing18ffdgpositronemissiontomographyaretrospectivecohortstudy
AT kiyoharahiroki monitoringboneandsofttissuetumorsaftercarbonionradiotherapyusing18ffdgpositronemissiontomographyaretrospectivecohortstudy
AT ohnotatsuya monitoringboneandsofttissuetumorsaftercarbonionradiotherapyusing18ffdgpositronemissiontomographyaretrospectivecohortstudy
AT nakanotakashi monitoringboneandsofttissuetumorsaftercarbonionradiotherapyusing18ffdgpositronemissiontomographyaretrospectivecohortstudy
AT takagishikenji monitoringboneandsofttissuetumorsaftercarbonionradiotherapyusing18ffdgpositronemissiontomographyaretrospectivecohortstudy